BridgeBio Pharma
CA - Palo AltoPharmaceutical
Focus: BridgeBio Pharma is a specialty pharmaceutical company focused on genetic disease treatments, particularly rare diseases and oncology, headquartered in Palo Alto with 69 active job openings.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
74-19 this month
Cooling — net -19 jobs in 30d
37 added, 56 removed. Slower than typical.
Should You Work at BridgeBio Pharma?
AI assessmentAttractive for commercial and manufacturing professionals seeking rapid growth with a rare-disease focus, but research and development roles face execution risk on unproven pipeline programs.
Why Work Here
- One FDA-approved growth-stage product (ATTRUBY/acoramidis) with LOE protection until 2039 provides near-term revenue stability and commercial expansion opportunities.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
11 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth12.9yr
First-and-only FDA-approved TTR stabilizer offering 13+ years of exclusivity; core revenue engine supporting commercial infrastructure build-out.
Help build intelligence for BridgeBio Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.